BAIN CAPITAL SPECIALTY FINAN (BCSF) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:BCSF • US05684B1070

13.07 USD
-0.04 (-0.31%)
Last: Feb 9, 2026, 09:50 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

BCSF gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 238 industry peers in the Capital Markets industry. There are concerns on the financial health of BCSF while its profitability can be described as average. BCSF has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • BCSF had positive earnings in the past year.
  • In the past year BCSF has reported a negative cash flow from operations.
  • In the past 5 years BCSF has always been profitable.
  • The reported operating cash flow has been mixed in the past 5 years: BCSF reported negative operating cash flow in multiple years.
BCSF Yearly Net Income VS EBIT VS OCF VS FCFBCSF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

  • BCSF has a Return On Assets (3.43%) which is comparable to the rest of the industry.
  • BCSF's Return On Equity of 8.25% is in line compared to the rest of the industry. BCSF outperforms 51.68% of its industry peers.
  • BCSF has a Return On Invested Capital (3.88%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BCSF is below the industry average of 7.27%.
Industry RankSector Rank
ROA 3.43%
ROE 8.25%
ROIC 3.88%
ROA(3y)4.53%
ROA(5y)3.71%
ROE(3y)10.26%
ROE(5y)8.49%
ROIC(3y)4.13%
ROIC(5y)3.56%
BCSF Yearly ROA, ROE, ROICBCSF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

  • With a decent Profit Margin value of 33.45%, BCSF is doing good in the industry, outperforming 79.83% of the companies in the same industry.
  • BCSF's Profit Margin has declined in the last couple of years.
  • The Operating Margin of BCSF (46.62%) is better than 83.61% of its industry peers.
  • BCSF's Operating Margin has improved in the last couple of years.
  • The Gross Margin of BCSF (50.18%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of BCSF has grown nicely.
Industry RankSector Rank
OM 46.62%
PM (TTM) 33.45%
GM 50.18%
OM growth 3Y2.21%
OM growth 5Y2.08%
PM growth 3Y-12.39%
PM growth 5Y-3.82%
GM growth 3Y2.62%
GM growth 5Y2.37%
BCSF Yearly Profit, Operating, Gross MarginsBCSF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • BCSF has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BCSF has been increased compared to 5 years ago.
  • BCSF has a worse debt/assets ratio than last year.
BCSF Yearly Shares OutstandingBCSF Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BCSF Yearly Total Debt VS Total AssetsBCSF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 0.57, we must say that BCSF is in the distress zone and has some risk of bankruptcy.
  • BCSF has a Altman-Z score of 0.57. This is comparable to the rest of the industry: BCSF outperforms 43.28% of its industry peers.
  • BCSF has a Debt/Equity ratio of 1.33. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.33, BCSF is not doing good in the industry: 65.55% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Altman-Z 0.57
ROIC/WACCN/A
WACCN/A
BCSF Yearly LT Debt VS Equity VS FCFBCSF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.31 indicates that BCSF should not have too much problems paying its short term obligations.
  • BCSF's Current ratio of 1.31 is fine compared to the rest of the industry. BCSF outperforms 63.45% of its industry peers.
  • BCSF has a Quick Ratio of 1.31. This is a normal value and indicates that BCSF is financially healthy and should not expect problems in meeting its short term obligations.
  • BCSF's Quick ratio of 1.31 is fine compared to the rest of the industry. BCSF outperforms 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
BCSF Yearly Current Assets VS Current LiabilitesBCSF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for BCSF have decreased by -8.06% in the last year.
  • Measured over the past 5 years, BCSF shows a small growth in Earnings Per Share. The EPS has been growing by 5.38% on average per year.
  • Looking at the last year, BCSF shows a decrease in Revenue. The Revenue has decreased by -5.41% in the last year.
  • BCSF shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.14% yearly.
EPS 1Y (TTM)-8.06%
EPS 3Y15.4%
EPS 5Y5.38%
EPS Q2Q%-15.09%
Revenue 1Y (TTM)-5.41%
Revenue growth 3Y14.03%
Revenue growth 5Y8.14%
Sales Q2Q%-6.21%

3.2 Future

  • BCSF is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -9.67% yearly.
  • BCSF is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.63% yearly.
EPS Next Y-7.76%
EPS Next 2Y-10.17%
EPS Next 3Y-9.67%
EPS Next 5YN/A
Revenue Next Year-4.58%
Revenue Next 2Y-5.29%
Revenue Next 3Y-4.63%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BCSF Yearly Revenue VS EstimatesBCSF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
BCSF Yearly EPS VS EstimatesBCSF Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 6.74, the valuation of BCSF can be described as very cheap.
  • Based on the Price/Earnings ratio, BCSF is valued cheaper than 82.35% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.93, BCSF is valued rather cheaply.
  • A Price/Forward Earnings ratio of 7.75 indicates a rather cheap valuation of BCSF.
  • 86.55% of the companies in the same industry are more expensive than BCSF, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.77, BCSF is valued rather cheaply.
Industry RankSector Rank
PE 6.74
Fwd PE 7.75
BCSF Price Earnings VS Forward Price EarningsBCSF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BCSF Per share dataBCSF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • A cheap valuation may be justified as BCSF's earnings are expected to decrease with -9.67% in the coming years.
PEG (NY)N/A
PEG (5Y)1.25
EPS Next 2Y-10.17%
EPS Next 3Y-9.67%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • BCSF has a Yearly Dividend Yield of 12.81%, which is a nice return.
  • BCSF's Dividend Yield is rather good when compared to the industry average which is at 6.13. BCSF pays more dividend than 83.61% of the companies in the same industry.
  • BCSF's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 12.81%

5.2 History

  • The dividend of BCSF has a limited annual growth rate of 2.77%.
  • BCSF has been paying a dividend for over 5 years, so it has already some track record.
  • BCSF has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.77%
Div Incr Years3
Div Non Decr Years3
BCSF Yearly Dividends per shareBCSF Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 156.46% of the earnings are spent on dividend by BCSF. This is not a sustainable payout ratio.
  • The Dividend Rate of BCSF has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP156.46%
EPS Next 2Y-10.17%
EPS Next 3Y-9.67%
BCSF Yearly Income VS Free CF VS DividendBCSF Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M
BCSF Dividend Payout.BCSF Dividend Payout, showing the Payout Ratio.BCSF Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BAIN CAPITAL SPECIALTY FINAN

NYSE:BCSF (2/9/2026, 9:50:59 AM)

13.07

-0.04 (-0.31%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-10
Earnings (Next)03-03
Inst Owners35.64%
Inst Owner Change-0.75%
Ins Owners0.64%
Ins Owner Change0%
Market Cap847.85M
Revenue(TTM)278.35M
Net Income(TTM)93.11M
Analysts80
Price Target15.13 (15.76%)
Short Float %0.63%
Short Ratio0.8
Dividend
Industry RankSector Rank
Dividend Yield 12.81%
Yearly Dividend1.77
Dividend Growth(5Y)2.77%
DP156.46%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.38%
Min EPS beat(2)-1.96%
Max EPS beat(2)4.72%
EPS beat(4)3
Avg EPS beat(4)3.51%
Min EPS beat(4)-1.96%
Max EPS beat(4)7.71%
EPS beat(8)4
Avg EPS beat(8)1.01%
EPS beat(12)6
Avg EPS beat(12)2.94%
EPS beat(16)8
Avg EPS beat(16)5.98%
Revenue beat(2)1
Avg Revenue beat(2)-1.38%
Min Revenue beat(2)-5.24%
Max Revenue beat(2)2.49%
Revenue beat(4)1
Avg Revenue beat(4)-5.72%
Min Revenue beat(4)-12.42%
Max Revenue beat(4)2.49%
Revenue beat(8)4
Avg Revenue beat(8)-1.03%
Revenue beat(12)6
Avg Revenue beat(12)0.75%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)-2.2%
PT rev (3m)-8.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.02%
EPS NY rev (1m)0%
EPS NY rev (3m)1.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.44%
Valuation
Industry RankSector Rank
PE 6.74
Fwd PE 7.75
P/S 3.05
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)1.94
EY14.84%
EPS(NY)1.69
Fwd EY12.9%
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS4.29
BVpS17.4
TBVpS17.4
PEG (NY)N/A
PEG (5Y)1.25
Graham Number27.56
Profitability
Industry RankSector Rank
ROA 3.43%
ROE 8.25%
ROCE 4.91%
ROIC 3.88%
ROICexc 3.97%
ROICexgc 4%
OM 46.62%
PM (TTM) 33.45%
GM 50.18%
FCFM N/A
ROA(3y)4.53%
ROA(5y)3.71%
ROE(3y)10.26%
ROE(5y)8.49%
ROIC(3y)4.13%
ROIC(5y)3.56%
ROICexc(3y)4.22%
ROICexc(5y)3.66%
ROICexgc(3y)4.24%
ROICexgc(5y)3.67%
ROCE(3y)5.23%
ROCE(5y)4.51%
ROICexgc growth 3Y15.38%
ROICexgc growth 5Y11.17%
ROICexc growth 3Y15.28%
ROICexc growth 5Y11.09%
OM growth 3Y2.21%
OM growth 5Y2.08%
PM growth 3Y-12.39%
PM growth 5Y-3.82%
GM growth 3Y2.62%
GM growth 5Y2.37%
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.68
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 0.57
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.06%
EPS 3Y15.4%
EPS 5Y5.38%
EPS Q2Q%-15.09%
EPS Next Y-7.76%
EPS Next 2Y-10.17%
EPS Next 3Y-9.67%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.41%
Revenue growth 3Y14.03%
Revenue growth 5Y8.14%
Sales Q2Q%-6.21%
Revenue Next Year-4.58%
Revenue Next 2Y-5.29%
Revenue Next 3Y-4.63%
Revenue Next 5YN/A
EBIT growth 1Y-7.43%
EBIT growth 3Y16.55%
EBIT growth 5Y10.39%
EBIT Next Year688.74%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-113.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-113.17%
OCF growth 3YN/A
OCF growth 5YN/A

BAIN CAPITAL SPECIALTY FINAN / BCSF FAQ

Can you provide the ChartMill fundamental rating for BAIN CAPITAL SPECIALTY FINAN?

ChartMill assigns a fundamental rating of 4 / 10 to BCSF.


What is the valuation status for BCSF stock?

ChartMill assigns a valuation rating of 5 / 10 to BAIN CAPITAL SPECIALTY FINAN (BCSF). This can be considered as Fairly Valued.


How profitable is BAIN CAPITAL SPECIALTY FINAN (BCSF) stock?

BAIN CAPITAL SPECIALTY FINAN (BCSF) has a profitability rating of 5 / 10.


What is the valuation of BAIN CAPITAL SPECIALTY FINAN based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BAIN CAPITAL SPECIALTY FINAN (BCSF) is 6.74 and the Price/Book (PB) ratio is 0.75.


What is the financial health of BAIN CAPITAL SPECIALTY FINAN (BCSF) stock?

The financial health rating of BAIN CAPITAL SPECIALTY FINAN (BCSF) is 2 / 10.